Age-related variations in presentation and outcome in Wegener's granulomatosis

Journal of the Royal College of Physicians of London

Volumn 31, Issue 4, 1997, Pages 396-400

  Vassallo, M ^a   Shepherd, R J ^a   Iqbal, P ^a   Feehally, J ^a  

^a King's Mill Centre ^*

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RETROSPECTIVE STUDY; WEGENER GRANULOMATOSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTINEOPLASTIC AGENTS, ALKYLATING; CAUSE OF DEATH; CYCLOPHOSPHAMIDE; FEMALE; GLUCOCORTICOIDS; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; WEGENER GRANULOMATOSIS;

EID: 0030856937     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Wegener F. Über generalisierte septische Gefässerkrankungen. Verhandl Deutsch Path Gesellsch 1936;29:202-10.
2. Dreisin RB. New perspectives in Wegener's granulomatosis. Thorax 1993;48:97-9.
3. Gross WL, Ludemann G, Kiefer G, Lehmann H. Anticytoplasmic antibodies in Wegener's granulomatosis (letter) Lancet 1986;i:806.
4. Andrews M, Edmunds M, Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980s - is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J Roy Coll Physicians London 1990;24:284-8.
5. Gross WL, Rasmussen N (editorial). Treatment of Wegener's granulomatosis: the view from two non-nephrologists. Nephrol Dial Transplant 1994;9:1219-25.
6. Herrero-Beaumont G, Armas JB, Amorim R, Shenstone B, et al. Limited forms of Wegener's granulomatosis presenting as polymyalgia rheumatica. Br J Rheumatol 1991;30:382-4.
7. Leitch DN, Heald A, Goodship THJ. Wegener's granulomatosis: an unusual presentation. Nephrol Dial Transplant 1994;9:421-2.
8. Chakravarty K, Scott DG, Blyth J, Courteney-Harris RG. Wegener's granulomatosis in the elderly - unusual presentations and misdiagnosis. J Rheumatol 1994;21:1157-9.
9. Leavitt RY, Fauci AS, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
10. Jennett JC, Falk RJ, Andrassy K, Bacon PA, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference (Review). Arthritis Rheum 1994;37:187-92.
11. Hoffman GS, Kerr GS, Leavitt RY, Hallahan GW, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
12. Anderson G, Coles ET, Crane M, Douglass AC, et al. Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a subcommittee of the British Thoracic Society Research Committee. Q J Med 1992;83:427-38.
13. Luqmani RA, Bacon PA, Beaman M, Scott DGI, et al. Classical versus non-renal Wegener's granulomatosis. Q J Med 1994; 87:161-7.
14. Barksdale SK, Hallahan CW, Kerr GS, Fauci AS, et al. Cutaneous pathology in Wegener's granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients. Am J SurgPathol 1995;19:161-72.
15. Briedigkeit L, Kettritz R, Gobel U, Natusch R. Prognostic factors in Wegener's granulomatosis. Postgrad Med J 1993;69:856-61.
16. Jennette JC, Falk RJ. Anti-neutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 1990;15:517-29.